nicotine replacement therapy

Electronic Cigarettes for Smoking Cessation: An Updated Review

By MedXY 12/18/2025

This review examines the safety and effectiveness of electronic cigarettes as aids to quit smoking, showing increased abstinence rates compared to traditional therapies and no significant serious adverse events reported.

news Public Health Respiratory

Nicotine E-Cigarettes Show Higher Quit Rates Than Traditional Nicotine Replacement Therapy

By MedXY 12/17/2025

Updated Cochrane review finds nicotine e-cigarettes increase smoking cessation success compared to NRT and non-nicotine e-cigarettes, with no clear difference in serious adverse events.

Nursing & care Pediatrics Psychiatry Specialties

Automated Tobacco Cessation for Parents in Pediatric Care: A Cluster-Randomized Trial Insights

By MedXY 09/11/2025

This cluster-randomized trial evaluated an automated tobacco cessation intervention for parents in pediatric primary care, finding no significant increase in 1-year quit rates but notable improvements in treatment engagement and smoking reduction.

Clinical Updates news Psychiatry Specialties

Optimizing Smoking Cessation in Major Depressive Disorder: Varenicline Outperforms Bupropion and Nicotine Patch with Comparable Safety

By MedXY 08/28/2025

This analysis reveals that varenicline is the most effective and safe pharmacotherapy for smoking cessation in individuals with current or past major depressive disorder, outperforming bupropion and nicotine patches with no increased neuropsychiatric risks.

Clinical Updates news Psychiatry Specialties

E-cigarettes versus Combination Nicotine Replacement Therapy for Smoking Cessation in Substance Use Disorder Patients: Integrative Analysis of Recent Trials and Longitudinal Patterns

By MedXY 08/02/2025

Recent trials show no significant difference in smoking cessation rates between e-cigarettes and combination nicotine replacement therapy among patients discharged from inpatient substance use withdrawal services. Longitudinal analyses reveal variable abstinence trajectories in e-cigarette trials, underscoring the need for further relapse-focused research.